Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders
Authors: Yonwoo Jung, Rachel A. Montel, Pei-Hong Shen, Deborah C. Mash, David Goldman
Journal: JAMA Network Open (2019)

<h3>Importance</h3> The association between the D2 dopamine receptor gene (<i>DRD2</i>) Taq1A locus (rs1800497) and alcohol use disorder (AUD) is enduring but the subject of long-standing controversy; meta-analysis of studies across 3 decades shows an association between rs1800497 and AUD, but genome-wide analyses have detected no role for rs1800497 in any phenotype. No evidence has emerged that rs1800497, which is located in<i>ANKK1</i>, perturbs the expression or function of<i>DRD2</i>. <h3>Objective</h3> To resolve contradictions in previous studies by identifying hidden confounders and assaying for functional effects of rs1800497 and other loci in the<i>DRD2</i>region. <h3>Data Sources</h3> PubMed (882 studies), Embase (1056 studies), and Web of Science (501 studies) databases were searched through August 2018. Three clinical populations—Finnish, Native American, and African American participants—were genotyped for 208 to 277 informative single-nucleotide polymorphisms (SNPs) across the<i>DRD2</i>region to test the associations of SNPs in this region with AUD. <h3>Study Selection</h3> Eligible studies had diagnosis of AUD made by accepted criteria, reliable genotyping methods, sufficient genotype data to calculate odds ratios and 95% CIs, and availability of control allele frequencies or genotype frequencies. <h3>Data Extraction and Synthesis</h3> After meta-analysis of 62 studies, metaregression was performed to detect between-study heterogeneity and to explore the effects of moderators, including deviations of cases and controls from allele frequencies in large population databases (ExAC and 1000 Genomes). Linkage to AUD and the effect on gene expression of rs1800497 were evaluated in the context of other SNPs in the<i>DRD2</i>region. Data analysis was performed from August 2018 to March 2019. This study follows the Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guideline. <h3>Main Outcomes and Measures</h3> The effects of rs1800497 and other SNPs in the<i>DRD2</i>region on gene expression were measured in human postmortem brain samples via differential allelic expression and evaluated in other tissues via publicly available expression quantitative locus data. <h3>Results</h3> A total of 62 studies of<i>DRD2</i>and AUD with 16 294 participants were meta-analyzed. The rs1800497 SNP was associated with AUD (odds ratio, 1.23; 95% CI, 1.14-1.31;<i>P</i> &lt; .001). However, the association was attributable to spuriously low allele frequencies in controls in positive studies, which also accounted for some between-study heterogeneity (<i>I2</i> = 43%; 95% CI, 23%-58%;<i>Q</i><sub>61</sub> = 107.20). Differential allelic expression of human postmortem brain and analysis of expression quantitative loci in public data revealed that a cis-acting locus or loci perturb the<i>DRD2</i>transcript level; however, rs1800497 does not and is not in strong disequilibrium with such a locus. Across the<i>DRD2</i>region, other SNPs are more strongly associated with AUD than rs1800497, although no<i>DRD2</i>SNP was significantly associated in these 3 clinical samples. <h3>Conclusions and Relevance</h3> In this meta-analysis, the significant association of<i>DRD2</i>with AUD was reassessed. The<i>DRD2</i>association was attributable to anomalously low control allele frequencies, not function, in positive studies. For genetic studies, statistical replication is not verification.